<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03677583</url>
  </required_header>
  <id_info>
    <org_study_id>NL66051.081.18</org_study_id>
    <nct_id>NCT03677583</nct_id>
  </id_info>
  <brief_title>Duckweed Intake Study</brief_title>
  <acronym>DIS</acronym>
  <official_title>Tolerance of Regular Intake of Duckweed Based Food Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wageningen University and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to study the impact of frequent intake of 150-180 gram duckweed on
      gastrointestinal complaints and several other health related biomarkers. The study has a
      randomised parallel design. Two different treatments will be evaluated e.g. a 11-day
      intervention with duckweed based meals and a 11-day intervention with control/spinach meals.
      At the start and at the end of the intervention we will collect a blood sample and a urine
      samples. Questionnaires about gut complaints, stool consistency and frequency, wellbeing,
      health complaints or other adverse effects will be collected daily during intervention and up
      to two days after the intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to study the impact of frequent intake of 150-180 gram duckweed on
      gastrointestinal complaints and several other health related biomarkers.

      Objective: The primary objective is to investigate gastro-intestinal complaints during 11 day
      duckweed consumption. Secondary objectives are to assess blood based parameters related to
      general health and urine based biomarkers for kidney function and to investigate consumer
      acceptance.

      Study design: The study has a randomised parallel design. Two different treatments will be
      evaluated e.g. a 11-day intervention with duckweed based meals and a 11-day intervention with
      control/spinach meals. At the start and at the end of the intervention we will collect a
      blood sample and a urine samples. Questionnaires about gut complaints, stool consistency and
      frequency, wellbeing, health complaints or other adverse effects will be collected daily
      during intervention and up to two days after the intervention.

      Study population: We aim to include 24 healthy volunteers aged 18-50 years. Intervention: A
      11-day intervention in which subjects will receive a daily lunch with 150-180g wet weight
      duck weed or spinach. Products will be incorporated in food products such as pasta, curry,
      soup etc.

      Main study parameters/endpoints: The main study parameter is frequency and severity of
      gastro-intestinal complaints. Secondary outcomes are intestinal health parameters derived
      from blood and urine samples taken before and after the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">October 15, 2018</completion_date>
  <primary_completion_date type="Actual">October 14, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in gastro-intestinal complaints</measure>
    <time_frame>Daily, during 11 days of duckweed intake and up to three days after intake. By questionnaires and Visual Analogue Scale (VAS) scores; from no complains (minimal) to serious complains (maximum)). Higher values represent a worse outcome</time_frame>
    <description>bloated feeling, belching, abdominal pain, flatulence, nausea, diarrhoea, constipation measured via Visual Analogue Scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in blood hemoglobin</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood glucose</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood Fe (Iron)</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood leukocyte cell counts</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood ALAT</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood GGT</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood eGFR</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood creatinine</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood CRP</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood zonulin</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>under fasting conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in urinary biomarkers of health</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>oxalic acid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in blood pressure</measure>
    <time_frame>before (D=0) and after (D=11) 11 days of duckweed or spinach intake</time_frame>
    <description>systolic and diastolic bloodpressure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>fiber, fruit and vegetable intake</measure>
    <time_frame>before the intervention (D=0), this questionaire provides insights in energy and macronutrient consumption</time_frame>
    <description>via a food frequency questionaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Gastrointestinal Complication</condition>
  <arm_group>
    <arm_group_label>Duckweed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>daily lunch with 150-180g wet weight duck weed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>daily lunch with 150-180g wet weight spinach</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Duckweed</intervention_name>
    <description>various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce</description>
    <arm_group_label>Duckweed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinach</intervention_name>
    <description>various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce</description>
    <arm_group_label>Spinach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Apparently healthy men and women

          -  Age between 18 and 50 years

          -  Body mass index (BMI) between 18.5 and 24.9 kg/m2

        Exclusion criteria

          -  Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes,
             anaemia, hepatitis, cardiovascular disease)

          -  History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints

          -  History of liver dysfunction (cirrhosis, hepatitis) or liver surgery

          -  Kidney dysfunction (self-reported)

          -  Use of medication that may influence the study results, such as gastric acid
             inhibitors or laxatives

          -  Reported slimming, medically prescribed or vegan/vegetarian diet

          -  Current smokers

          -  Alcohol intake â‰¥4 glasses of alcoholic beverages per day

          -  Pregnant, lactating or wishing to become pregnant in the period of the study
             (self-reported)

          -  Abuse of illicit drugs

          -  Food allergies for products that we use in the study

          -  Participation in another clinical trial at the same time

          -  Being an employee of the department Consumer Science &amp; Health group of Wageningen Food
             &amp; Biobased Research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diederik Esser, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stichting Wageningen Research</name>
      <address>
        <city>Wageningen</city>
        <state>Gelderland</state>
        <zip>6708 WG</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 6, 2018</study_first_submitted>
  <study_first_submitted_qc>September 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2018</study_first_posted>
  <last_update_submitted>October 19, 2018</last_update_submitted>
  <last_update_submitted_qc>October 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wageningen University and Research</investigator_affiliation>
    <investigator_full_name>Diederik Esser</investigator_full_name>
    <investigator_title>project leader clinical trials</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

